Lab4 Probiotics

Lab4 Probiotics is a research-driven biotechnology brand and consortium of probiotic strains developed by Cultech Limited. The consortium consists of four specific strains of lactic acid bacteria—Lactobacillus acidophilus (CUL60 and CUL21), Bifidobacterium bifidum (CUL20), and Bifidobacterium animalis subsp. lactis (CUL34)—that have been extensively studied in over 30 clinical trials. The company focuses on the development and manufacture of evidence-based probiotic formulations for various health indications, including digestive health, immunity, and metabolic support. Their products are utilized globally by healthcare practitioners and retail brands, supported by a robust clinical research program and state-of-the-art manufacturing facilities in the UK. Lab4 Probiotics is recognized for its commitment to stability and efficacy, employing proprietary technologies to ensure the viability of its microbial strains.